Amazon stock gets a new Wegovy catalyst — what could move AMZN next week
New York, Jan 11, 2026, 09:36 EST — Market closed. Amazon.com’s online pharmacy has started selling Novo Nordisk’s newly approved Wegovy weight-loss pill, expanding the retailer’s health services just before the next U.S. trading session. On Friday, Amazon shares ended the day 0.44% higher, closing at $247.38. Amazon’s new launch marks its entry into the fast-growing GLP-1 drug market—medicines that…